Article Details
Retrieved on: 2021-07-08 20:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... and novel glycosylation technologies to rapidly deliver high-quality monoclonal antibodies, vaccines, bioinks and other proteins. iBio is developing ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here